Colon hydration offers alternative to OSP for bowel prep
June 30, 2009
Pharmaceutical
Some hospitals across the country are choosing an alternative method of prepping the bowel before colonoscopies that does not require patients to drink a gallon of liquid laxatives the day before the procedure, according to EndoNurse. The new procedure is ... Read More
FDA warns about qualaquin use for restless leg syndrome
June 30, 2009
Product Liability
The Food and Drug Administration (FDA) has issued a warning to health care professionals to use extreme caution when prescribing Qualaquin (Quinine Sulfate), according to the Postmarket Reviews section of the Volume 2, Number 2 2, 2009 issue of its ... Read More
Families of nursing home abuse victims speak out using social media
June 29, 2009
Personal Injury
It was almost unbelievable, the reports of patients being physically and sexually abused by nursing home aides at Good Samaritan Society of Albert Lea in Minnesota. The aides said they didn’t mean any harm when they held down patients, shoved ... Read More
C.B. Fleet wants to put recalled products back on market
June 29, 2009
Pharmaceutical
Maker of bowel cleansing products and laxatives C.B. Fleet wants to sell its over-the-counter oral sodium phosphate (OSP) solutions to consumers even though the company recalled them six months ago after the Food and Drug Administration (FDA) issued black box ... Read More
Pain pump makers may be liable for injury after shoulder surgery
June 29, 2009
Pharmaceutical
For a long time, physicians didn’t know why patients who had shoulder surgery began suffering from a painful condition known as chondrolysis, in which the patient loses the cartilage in the shoulder. “This goes all the way back to about ... Read More
Investigators still baffled over cookie dough contamination
June 29, 2009
Product Liability
Food safety authorities and microbiologists arrived at Nestle’s Danville, Virginia plant to investigate the likely presence of E. coli bacteria in refrigerated cookie dough products. The Food and Drug Administration and the Centers for Disease Control and Prevention have been ... Read More
Clinical trials seek treatment for Tardive Dyskinesia
June 27, 2009
Pharmaceutical
Three clinical trials seeking treatments for a neurological disorder known as Tardive Dyskinesia are currently seeking volunteers. The studies – Efficacy of Docosahexaenoic Acid on Tardive Dyskinesia, Safety and Efficacy of Avastrem (Pryidoxal 5’ –Phosphate) in the Treatment of Tardive Dyskinesia, and ... Read More
Pregnant women beware: Some medications can be lethal to fetus
June 27, 2009
Pharmaceutical
In 2005, GlaxoSmithKline informed health care professionals that it was updating the Pregnancy subsection of the PRECAUTIONS section of the labels for its popular antidepressant medication Paxil to indicate the risk of possible side effects based on a study conducted ... Read More
Researchers working on safer synthetic HRT for menopause
June 27, 2009
Pharmaceutical
Researchers in Ottawa, Canada are hoping to ease women’s fear of hormone replacement drugs by creating and testing synthetic hormones to combat aggravating symptoms of menopause, according to Canada.com. The research follows an earlier grant from the Canadian Breast Cancer ... Read More
Cancer drug linked to serious skin condition SJS/TEN
June 27, 2009
Pharmaceutical
The Food and Drug Administration (FDA) along with OSI Pharmaceuticals, Inc. and Genetech has announced that new safety information has been added to the WARNINGS AND PRECAUTIONS sections of the prescribing information for the cancer drug erlotinib, known by the ... Read More